# Mass Balance of Orally Administered [14C] (3S,4S,5R)-1,3,4,5,6-pentahydroxy-hexan-2-one

> **NCT06230900** · NA · COMPLETED · sponsor: **Wageningen University** · enrollment: 8 (actual)

## Conditions studied

- Energy Intake
- Energy Metabolism

## Interventions

- **OTHER:** (3S,4S,5R)-1,3,4,5,6-pentahydroxy-hexan-2-one
- **COMBINATION_PRODUCT:** 14C-(3S,4S,5R)-1,3,4,5,6-pentahydroxy-hexan-2-one

## Key facts

- **NCT ID:** NCT06230900
- **Lead sponsor:** Wageningen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-02-05
- **Primary completion:** 2025-04-19
- **Final completion:** 2025-04-19
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2025-04-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06230900

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06230900, "Mass Balance of Orally Administered [14C] (3S,4S,5R)-1,3,4,5,6-pentahydroxy-hexan-2-one". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06230900. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*